FibroGen Inc.

NASDAQ: FGEN · Real-Time Price · USD
9.49
0.01 (0.11%)
At close: Aug 15, 2025, 3:59 PM
9.44
-0.58%
After-hours: Aug 15, 2025, 06:37 PM EDT

FibroGen Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
29.62M 46.8M 140.73M 235.31M
Cost of Revenue
15.56M 3.96M 20.28M 12.87M
Gross Profit
14.06M 42.84M 120.45M 222.44M
Operating Income
-150.42M -322.72M -301.02M -288.53M
Interest Income
5.3M 7.59M 7.6M 1.01M
Pretax Income
-153.37M -323.22M -293.3M -290.68M
Net Income
-47.58M -284.23M -293.65M -291.03M
Selling & General & Admin
49.33M 86.48M 124.69M 123.92M
Research & Development
95.69M 266.47M 296.79M 387.04M
Other Expenses
19.45M 12.61M n/a n/a
Operating Expenses
164.48M 365.56M 421.48M 510.97M
Interest Expense
8.25M 8.1M 1.44M 2.15M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
180.04M 369.52M 441.76M 523.84M
Income Tax Expense
-269K -252K 358K 347K
Shares Outstanding (Basic)
100.04M 97.3M 93.58M 92.35M
Shares Outstanding (Diluted)
100.04M 97.3M 93.58M 92.35M
EPS (Basic)
-0.48 -2.92 -3.15 -3.15
EPS (Diluted)
-0.48 -2.92 -3.15 -3.15
EBITDA
-142.43M -305.2M -282.82M -274.8M
EBIT
-145.12M -315.13M -293.43M -289.61M
Depreciation & Amortization
2.69M 9.93M 10.6M 14.81M